Table S1 Primers used in this report. A list of all primers used throughout this investigation is sectioned according to the general application for which they were designed. Associated with each primer is the sequence, the Tm at which it was utilized, as well as a note specifying its particular application. Found at: doi:10.1371/journal.pone.0005761.s007 (0.07 MB XLS) References 1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860–921. 2. Dewannieux M, Esnault C, Heidmann T (2003) LINE-mediated retrotranspo- sition of marked Alu sequences. Nat Genet 35: 41–48. 3. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520–562. 4. Smit AF (1996) The origin of interspersed repeats in the human genome. Curr Opin Genet Dev 6: 743–748. 5. Brosius J (1999) RNAs from all categories generate retrosequences that may be exapted as novel genes or regulatory elements. Gene 238: 115–134. 6. Medstrand P, van de Lagemaat LN, Mager DL (2002) Retroelement distributions in the human genome: variations associated with age and proximity to genes. Genome Res 12: 1483–1495. 7. Nigumann P, Redik K, Matlik K, Speek M (2002) Many human genes are transcribed from the antisense promoter of L1 retrotransposon. Genomics 79: 628–634. 8. van de Lagemaat LN, Landry JR, Mager DL, Medstrand P (2003) Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions. Trends Genet 19: 530–536. 9. Hasler J, Samuelsson T, Strub K (2007) Useful ‘junk’: Alu RNAs in the human transcriptome. Cell Mol Life Sci 64: 1793–1800. 10. Makalowski W, Mitchell GA, Labuda D (1994) Alu sequences in the coding regions of mRNA: a source of protein variability. Trends Genet 10: 188–193. 11. Sorek R, Ast G, Graur D (2002) Alu-containing exons are alternatively spliced. Genome Res 12: 1060–1067. 12. Lin L, Shen S, Tye A, Cai JJ, Jiang P, et al. (2008) Diverse splicing patterns of exonized Alu elements in human tissues. PLoS Genet 4: e1000225. 13. Shankar R, Grover D, Brahmachari SK, Mukerji M (2004) Evolution and distribution of RNA polymerase II regulatory sites from RNA polymerase III dependant mobile Alu elements. BMC Evol Biol 4: 37. 14. Tomilin NV (2008) Regulation of mammalian gene expression by retroelements and non-coding tandem repeats. Bioessays 30: 338–348. 15. Romanish MT, Lock WM, van de Lagemaat LN, Dunn CA, Mager DL (2007) Repeated recruitment of LTR retrotransposons as promoters by the anti- apoptotic locus NAIP during mammalian evolution. PLoS Genet 3: e10. 16. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, et al. (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167–178. 17. Davoodi J, Lin L, Kelly J, Liston P, MacKenzie AE (2004) Neuronal apoptosis- inhibitory protein does not interact with Smac and requires ATP to bind caspase-9. J Biol Chem 279: 40622–40628. 18. Maier JK, Lahoua Z, Gendron NH, Fetni R, Johnston A, et al. (2002) The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 22: 2035–2043. 19. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, et al. (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349–353. 20. Liston P, Fong WG, Korneluk RG (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22: 8568–8580. 21. Langemeijer SM, de Graaf AO, Jansen JH (2008) IAPs as therapeutic targets in haematological malignancies. Expert Opin Ther Targets 12: 981–993. 22. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17: 3247–3259. 23. Hebb AL, Moore CS, Bhan V, Campbell T, Fisk JD, et al. (2008) Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Mult Scler 14: 577–594. 24. Seidl R, Bajo M, Bohm K, LaCasse EC, MacKenzie AE, et al. (1999) Neuronal apoptosis inhibitory protein (NAIP)-like immunoreactivity in brains of adult patients with Down syndrome. J Neural Transm Suppl 57: 283–291. 25. Diez E, Lee SH, Gauthier S, Yaraghi Z, Tremblay M, et al. (2003) Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumo- phila. Nat Genet 33: 55–60. 26. Ren T, Zamboni DS, Roy CR, Dietrich WF, Vance RE (2006) Flagellin- deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog 2: e18. Novel Promoters for Human NAIP Acknowledgments We thank Drs. C. Eaves and P. Medstrand for human blood and placenta samples; Drs. R. Kay and C. Cohen for comments on the manuscript; and L. Gagnier and J. Ruschmann for technical assistance. Author Contributions Conceived and designed the experiments: MR DLM. Performed the experiments: MR CBL. Analyzed the data: MR. Contributed reagents/ materials/analysis tools: HN CBL YW. Wrote the paper: MR DLM. 27. Zamboni DS, Kobayashi KS, Kohlsdorf T, Ogura Y, Long EM, et al. (2006) The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol 7: 318–325. 28. Molofsky AB, Byrne BG, Whitfield NN, Madigan CA, Fuse ET, et al. (2006) Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J Exp Med 203: 1093–1104. 29. Harton JA, Linhoff MW, Zhang J, Ting JP (2002) Cutting edge: CATER- PILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol 169: 4088–4093. 30. Feschotte C (2008) Transposable elements and the evolution of regulatory networks. Nat Rev Genet 9: 397–405. 31. Chen Q, Baird SD, Mahadevan M, Besner-Johnston A, Farahani R, et al. (1998) Sequence of a 131-kb region of 5q13.1 containing the spinal muscular atrophy candidate genes SMN and NAIP. Genomics 48: 121–127. 32. Schmutz J, Martin J, Terry A, Couronne O, Grimwood J, et al. (2004) The DNA sequence and comparative analysis of human chromosome 5. Nature 431: 268–274. 33. Tran VK, Sasongko TH, Hong DD, Hoan NT, Dung VC, et al. (2008) SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy. Pediatr Int 50: 346–351. 34. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996–1006. 35. Maier JK, Balabanian S, Coffill CR, Stewart A, Pelletier L, et al. (2007) Distribution of neuronal apoptosis inhibitory protein in human tissues. J Histochem Cytochem 55: 911–923. 36. Xu M, Okada T, Sakai H, Miyamoto N, Yanagisawa Y, et al. (2002) Functional human NAIP promoter transcription regulatory elements for the NAIP and PsiNAIP genes. Biochim Biophys Acta 1574: 35–50. 37. Economou EP, Bergen AW, Warren AC, Antonarakis SE (1990) The polydeoxyadenylate tract of Alu repetitive elements is polymorphic in the human genome. Proc Natl Acad Sci U S A 87: 2951–2954. 38. Arcot SS, Wang Z, Weber JL, Deininger PL, Batzer MA (1995) Alu repeats: a source for the genesis of primate microsatellites. Genomics 29: 136–144. 39. Butler JE, Kadonaga JT (2002) The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 16: 2583–2592. 40. Lev-Maor G, Ram O, Kim E, Sela N, Goren A, et al. (2008) Intronic Alus influence alternative splicing. PLoS Genet 4: e1000204. 41. Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, et al. (2004) Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res 14: 1719–1725. 42. Kozak M (1987) An analysis of 59-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125–8148. 43. Nakagawa S, Niimura Y, Gojobori T, Tanaka H, Miura K (2008) Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes. Nucleic Acids Res 36: 861–871. 44. McClintock B (1953) Induction of Instability at Selected Loci in Maize. Genetics 38: 579–599. 45. Doolittle WF, Sapienza C (1980) Selfish genes, the phenotype paradigm and genome evolution. Nature 284: 601–603. 46. Lowe CB, Bejerano G, Haussler D (2007) Thousands of human mobile element fragments undergo strong purifying selection near developmental genes. Proc Natl Acad Sci U S A 104: 8005–8010. 47. Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, et al. (2006) In vivo enhancer analysis of human conserved non-coding sequences. Nature 444: 499–502. 48. Jordan IK, Rogozin IB, Glazko GV, Koonin EV (2003) Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet 19: 68–72. 49. Norris J, Fan D, Aleman C, Marks JR, Futreal PA, et al. (1995) Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor- dependent transcriptional enhancers. J Biol Chem 270: 22777–22782. 50. Lee JY, Ji Z, Tian B (2008) Phylogenetic analysis of mRNA polyadenylation sites reveals a role of transposable elements in evolution of the 39-end of genes. Nucleic Acids Res 36: 5581–5590. 51. Chen C, Ara T, Gautheret D (2009) Using Alu elements as polyadenylation sites: A case of retroposon exaptation. Mol Biol Evol 26: 327–334. PLoS ONE | www.plosone.org 11 June 2009 | Volume 4 | Issue 6 | e5761